一个临床产品都没有 这家公司为何2个月能融资近3亿美元?(2)
2019-12-12 未知 admin
我们期待在资本的助力下,IGM Biosciences能够早日在临床实验中验证技术平台的潜力,为全球病患带来更多治疗选择。
参考资料:
[1] IGM Biosciences Announces Pricing of Initial Public Offering, Retrieved September 18, 2019, from https://investor.igmbio.com/news-releases/news-release-details/igm-biosciences-announces-pricing-initial-public-offering
[2] Preclinical cancer biotech IGM Biosciences sets stage for upsized $175M IPO, Retrieved September, from https://endpts.com/preclinical-cancer-biotech-igm-biosciences-sets-stage-for-upsized-175m-ipo/
鐑瘝锛